|
|
| Fredun Pharmaceuticals Limited |
|
Financials-Fredun Pharmaceuticals Limited| Sector: Healthcare | | BSE:539730 | NSE:NA | Bloomberg:FREDUN@IN | Reuters:FRED.BO | | Market Lot: 1 | Face Value: 10 | ISIN Demat: INE194R01017 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
31-Mar-2021(3) |
31-Mar-2020(3) |
% Change |
| Sales of Products/Services |
411.23 |
244.21 |
68.39 |
| Other Operating Income |
0.00 |
0.00 |
-- |
| Other Income |
12.57 |
8.83 |
42.36 |
| Total Income |
423.80 |
253.04 |
67.48 |
| Total Expenses |
-413.72 |
-249.25 |
65.99 |
| OPBDIT |
837.52 |
502.29 |
66.74 |
| Interest |
0.00 |
0.00 |
-- |
| Depreciation |
-5.18 |
-249.25 |
-97.92 |
| Exceptional & Extraordinary Items |
0.00 |
0.00 |
-- |
| Prior Period Adjustments |
0.00 |
0.00 |
-- |
| Provision for Tax |
-2.80 |
-5.93 |
-52.78 |
| After Tax Profit |
7.27 |
-2.14 |
NM |
| Equity Capital |
0.00 |
0.00 |
-- |
| Reserves |
0.00 |
0.00 |
-- |
| Notes to Accounts |
|
|
|
|
| As on( Months ) |
31-Mar-02(12) |
|
31-Mar-01(12) |
|
31-Mar-00(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
52.44 |
81.65 |
31.36 |
70.78 |
44.79 |
93.66 |
| Operating Income (OI) |
64.23 |
100.00 |
44.30 |
100.01 |
47.82 |
100.00 |
| OPBDIT |
4.43 |
6.90 |
3.52 |
7.94 |
3.42 |
7.15 |
| OPBDT |
2.69 |
4.19 |
2.53 |
5.72 |
0.59 |
1.23 |
| OPBT |
0.90 |
1.40 |
0.89 |
2.01 |
-0.77 |
-1.61 |
| Non-Operating Income |
0.07 |
0.11 |
-0.01 |
-0.02 |
0.11 |
0.22 |
| Extraordinary/Prior Period |
-0.78 |
-1.22 |
-0.10 |
-0.22 |
0.12 |
0.25 |
| Tax |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Profit after tax(PAT) |
0.19 |
0.29 |
0.78 |
1.77 |
-0.54 |
-1.13 |
| Cash Profit |
5.52 |
8.59 |
2.42 |
5.47 |
0.82 |
1.71 |
| Dividend-Equity |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| As on |
31-Mar-02 |
|
31-Mar-01 |
|
31-Mar-00 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
39.14 |
64.95 |
27.68 |
56.21 |
25.25 |
49.68 |
| Net Block |
28.86 |
47.89 |
19.51 |
39.62 |
19.15 |
37.67 |
| Capital WIP |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Investments |
0.35 |
0.58 |
0.35 |
0.71 |
0.37 |
0.72 |
| Inventory |
8.13 |
13.49 |
6.66 |
13.54 |
3.35 |
6.59 |
| Receivables |
12.75 |
21.16 |
10.69 |
21.72 |
10.59 |
20.84 |
| Other Current Assets |
10.18 |
16.89 |
12.02 |
24.42 |
17.37 |
34.17 |
| Balance Sheet Total(BT) |
60.27 |
100.00 |
49.24 |
100.00 |
50.82 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
23.74 |
39.40 |
23.74 |
48.22 |
23.74 |
46.72 |
| Reserves |
-14.32 |
-23.76 |
-14.79 |
-30.03 |
-15.85 |
-31.20 |
| Total Debt |
25.20 |
41.82 |
21.42 |
43.51 |
23.57 |
46.38 |
| Creditors and Acceptances |
19.86 |
32.96 |
17.98 |
36.51 |
18.71 |
36.81 |
| Other current liab/prov. |
5.78 |
9.59 |
0.88 |
1.79 |
0.65 |
1.29 |
| Balance Sheet Total(BT) |
60.27 |
100.00 |
49.24 |
100.00 |
50.82 |
100.00 |
|
| As on |
31-Mar-02 |
31-Mar-01 |
31-Mar-00 |
| OPBIT/Prod.cap.empl.(%) |
7.71 |
6.26 |
6.64 |
| PBIT/Cap. Employed (%) |
5.57 |
5.83 |
7.29 |
| PAT/Networth (%) |
1.97 |
8.76 |
-6.85 |
| Tax/PBT (%) |
0.00 |
0.00 |
0.00 |
| Total Debt/Networth (x) |
2.67 |
2.39 |
2.99 |
| Long Term Debt/Networth (x) |
1.58 |
1.26 |
1.12 |
| PBDIT/Finance Charges (x) |
2.13 |
3.46 |
1.29 |
| Current Ratio (x) |
1.21 |
1.56 |
1.62 |
| RM Inventory (days consumption) |
67.13 |
103.39 |
46.13 |
| FG inventory (days cost of sales) |
5.30 |
3.01 |
0.27 |
| Receivables (days gross sales) |
88.38 |
124.39 |
85.56 |
| Creditors (days cost of sales) |
121.24 |
160.90 |
153.79 |
| Op. curr. assets (days OI) |
176.00 |
242.00 |
239.00 |
|
|
Financials